A safety profile of medications used to treat Waldenström’s macroglobulinemia

Taylor and Francis Group, Expert Opinion on Drug Safety, 6(17), p. 609-621, 2018

Journal article published in 2018 by Ramón García-Sanz

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by